SAPHYR results: SAR + 14 wk GC taper showed efficacy vs comparator arm in steroid refractory PMR, including clinically meaningful improvement in QoL. No new safety signals. Plenary Abs 1676 #ACR22 @RheumNow https://t.co/mHu3e9JbCp https://t.co/93kbczSTfS
Links:
Sarilumab in Patients with Relapsing Polymyalgia Rheumatica: A Phase 3, Multice…
http://ow.ly/lNh850LA4l1
14-11-2022